Mikart, LLC, a US-based Contract Development and Manufacturing Organisation (CDMO), announced on Thursday that it has added Fette double-sided tablet presses to increase its production capacity and meet the product demands of its increasing number of customers.
The tablet presses have advanced features, which include automatic weight control, metal detectors, dedusters and bulk powder feeding systems for optimal efficiency and precision of tablet production applications.
Michael Kallelis, Mikart, LLC CEO, said, 'We are thrilled to expand our Fette tablet press platforms into our manufacturing operations. These high-speed and high-volume presses mark a significant milestone in our journey towards enhancing client satisfaction and accommodating the growing brand and generic market.'
Aveva Drug Delivery systems introduces generic Fentanyl Transdermal Patch in US
Independent Pharmacy Cooperative signs cooperation agreement with Legacy Pharmacy Group
ILIKOS Consulting partners with Jordan Center for Pharmaceutical Research
Axsome Therapeutics settles patent litigation with Teva over AUVELITY
Breckenridge Pharmaceutical's Everolimus Tablets for Oral Suspension receive US FDA approval
Newbury Pharmaceuticals secures generic approval for pomalidomide in Denmark
Newbury Pharmaceuticals secures generic approval for Bosutinib in Norway
Guangzhou Fermion Technology partners with Simcere Pharmaceutical